Mr. Buccellato leads Hackensack Meridian Jersey Shore University Medical Center, where he has overseen significant growth in centers of excellence including neuroscience, oncology and cardiovascular services. Under his leadership, the medical center’s Dr. Robert H. and Mary Ellen Harris ZAP-X Center for Noninvasive Neurosurgery became the first site in the world to combine ZAP-X gyroscopic radiosurgery with Synaptive’s brain-only, silent MRI technology for treating brain tumors and conditions such as trigeminal neuralgia. The medical center was also the first hospital in New Jersey to offer histotripsy for liver and metastasized cancers and trans-arterial micro-perfusion therapy for advanced pancreatic cancer, and it opened a $45 million cardiovascular suite with four cardiac catheterization labs, four electrophysiology labs and two hybrid operating rooms. The hospital was ranked the eighth-best hospital in New Jersey by U.S. News & World Report in its 2026-2027 rankings. It also trains more than 190 resident and fellow physicians across 20 accredited programs in partnership with its academic affiliates. Mr. Buccellato serves on the boards of United Surgical Partners International and Neighborhood Health Providers.
